Montero-Vilchez, TrinidadValenzuela-Amigo, AndreaCuenca-Barrales, CarlosArias-Santiago, SalvadorLeyva-Garcia, AnaMolina-Leyva, Alejandro2023-02-092023-02-092021-07-12Montero-Vilchez T, Valenzuela-Amigo A, Cuenca-Barrales C, Arias-Santiago S, Leyva-García A, Molina-Leyva A. The Role of Oral Contraceptive Pills in Hidradenitis Suppurativa: A Cohort Study. Life (Basel). 2021 Jul 15;11(7):697.2075-1729http://hdl.handle.net/10668/18308There is a need to establish the role of antiandrogens as an alternative or concomitant therapy for hidradenitis suppurativa (HS). Thus, the objectives of this study are (1) to assess the effectiveness of oral contraceptive pills (OCPs) at week 12 in HS women, and (2) to describe the clinical profile of patients receiving oral contraceptive pills (OCPs). A prospective observational study was designed. This study included 100 participants, 50 women with HS who started OCPs for the first time at our HS Clinic and 50 participants without OCP treatment. The main outcome of interest was the percentage of reduction in total abscess and inflammatory nodule (AN) count at week 12. Thirty-three women received combined OCPs and 17 non-combined OCP. HS patients with OCPs treatment were younger (31.7 vs. 40.9 years, penAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/contraceptiveshidradenitis suppurativapremenstrual syndromeHumansFemaleAndrogen AntagonistsAbscessHidradenitis SuppurativaContraceptives, OralMenstrual Cycleresearch article34357069open accessAbscesoAntagonistas de andrógenosAnticonceptivos oralesCiclo menstrualFemeninoHidradenitis supurativaHumanos10.3390/life11070697PMC8307628https://www.mdpi.com/2075-1729/11/7/697/pdf?version=1626850876https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307628/pdf